Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

Medicine, Cardiology, Pharmacotherapy +13

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

J Ames S Hepherd, S Tuart M. C Obbe, I An F Ord et al. · 1995 · 3.5K citations

Medicine, Cardiology, Pharmacotherapy +12

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

Pertti J. Neuvonen, Kirsi-Maija Jalava · Clinical Pharmacology & Therapeutics · 1996 · 240 citations

Medicine, Pharmacokinetics, Pharmacology +13

Biotransformation of lovastatin

Regina W. Wang, Prasad H. Kari, Anthony Y.H. Lu et al. · Archives of Biochemistry and Biophysics · 1991 · 198 citations

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

C. Transon, T. Leemann, Pierre Dayer · European Journal of Clinical Pharmacology · 1996 · 173 citations

Medicine, Pharmacokinetics, Pharmacology +15